Skip to main content
Erschienen in: Journal of Infection and Chemotherapy 3/2013

01.06.2013 | Case Report

Usefulness of gram-stained sputum obtained just after administration of antimicrobial agents as the earliest therapeutic indicator for evaluating the effectiveness of empiric therapy in community-acquired pneumonia caused by pneumococcus or Moraxella catarrhalis

verfasst von: Ryuichi Fujisaki, Toshimori Yamaoka, Michiko Yamamura, Sayoko Kawakami, Yasuo Ono, Yukihisa Miyazawa, Tamio Teramoto, Hajime Nishiya

Erschienen in: Journal of Infection and Chemotherapy | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

We present here three cases in which morphological changes and/or a decreased number of Streptococcus pneumoniae or Moraxella catarrhalis could be observed in gram-stained sputum obtained just after the first administration of an antimicrobial agent. Case 1 was a 53-year-old man with pneumonia caused by gram-positive diplococcus, identified as S. pneumoniae, who was administered 2 g of ampicillin over a period of 1 h. Gram-stained sputum showed smaller or gram-negative pneumococci at the completion of administration of the agent, a decreased number of cocci at 1 h after administration, and almost no cocci at 12 h after the completion of administration. Case 2 was a 72-year-old woman with pneumonia caused by diplococcus, identified as S. pneumoniae, who was administered 2 g of ampicillin over a period of 1 h. Gram-stained sputum showed weakly stained, small cocci at the completion of administration of the agent and few cocci at 1 h after the completion of administration. Case 3 was a 58-year-old woman with pneumonia caused by a gram-negative diplococcus, identified as Moraxella catarrhalis, who was administered 1 g of cefotaxime over a period of 30 min. Gram-stained sputum showed few extracellular cocci and some intracellular cocci inside neutrophils 1 h after administration and no cocci 2 h after the completion of administration. These three cases showed that gram-stained sputum obtained just after and/or 1 h after administration of the first antimicrobial agent were suitable as the quickest therapeutic indicator of the effectiveness of empiric therapy, with the effectiveness of the agent being shown much earlier than with markers such as the white blood cell count and C-reactive protein level.
Literatur
1.
Zurück zum Zitat Garou J, Calbo E. Community-acquired pneumonia. Lancet. 2008;371:455–8.CrossRef Garou J, Calbo E. Community-acquired pneumonia. Lancet. 2008;371:455–8.CrossRef
2.
Zurück zum Zitat Restrepo MI, Anzueto A. Guidelines for the diagnoses and treatment of adult lower respiratory tract infections: a true “European cooperative effort”. Eur Respir J. 2005;26:979–81.PubMedCrossRef Restrepo MI, Anzueto A. Guidelines for the diagnoses and treatment of adult lower respiratory tract infections: a true “European cooperative effort”. Eur Respir J. 2005;26:979–81.PubMedCrossRef
3.
4.
Zurück zum Zitat Fine MJ, Smith MA, et al. Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis. JAMA. 1996;275:134–41.PubMedCrossRef Fine MJ, Smith MA, et al. Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis. JAMA. 1996;275:134–41.PubMedCrossRef
5.
Zurück zum Zitat Ewig S, Schlochtermeier M, Göke N, Niederman MS. Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions. Chest. 2002;121:1486–92.PubMedCrossRef Ewig S, Schlochtermeier M, Göke N, Niederman MS. Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions. Chest. 2002;121:1486–92.PubMedCrossRef
6.
Zurück zum Zitat Theerhakarai R, EI-Halees W, Ismal M, Solis RA, Khan MA. Nonvalue of the initial microbiological studies in the management of nonsevere community-acquired pneumonia. Chest. 2001;119:181–4.CrossRef Theerhakarai R, EI-Halees W, Ismal M, Solis RA, Khan MA. Nonvalue of the initial microbiological studies in the management of nonsevere community-acquired pneumonia. Chest. 2001;119:181–4.CrossRef
7.
Zurück zum Zitat Roson B, Carratala J, Verdaguer R, Dorca J, Manresa F, Gudiol F. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis. 2000;31:869–74.PubMedCrossRef Roson B, Carratala J, Verdaguer R, Dorca J, Manresa F, Gudiol F. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis. 2000;31:869–74.PubMedCrossRef
8.
Zurück zum Zitat The American Thoracic Society. Guidelines for the management of adults with community-aquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163:1730–54.CrossRef The American Thoracic Society. Guidelines for the management of adults with community-aquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163:1730–54.CrossRef
9.
Zurück zum Zitat The Committee for the JRS Guidelines in Management of Community-Acquired Pneumonia. In: Matsushima T, Kohno S, Saito A, Nakata K, Yamaguch K, Watanabe A, editors. Practice guideline for the management of community-acquired pneumonia in adults. Tokyo: The Japanese Respiratory Society; 2000 (in Japanese). The Committee for the JRS Guidelines in Management of Community-Acquired Pneumonia. In: Matsushima T, Kohno S, Saito A, Nakata K, Yamaguch K, Watanabe A, editors. Practice guideline for the management of community-acquired pneumonia in adults. Tokyo: The Japanese Respiratory Society; 2000 (in Japanese).
10.
Zurück zum Zitat Matsumoto K, Uzuka Y, Taguchi M, et al. Sputum bacteria quantification culture. Media Circle 1985;19:181–99 (in Japanese). Matsumoto K, Uzuka Y, Taguchi M, et al. Sputum bacteria quantification culture. Media Circle 1985;19:181–99 (in Japanese).
11.
Zurück zum Zitat Kanno S. Gram stain. Medicina 2005;42:545–48 (in Japanese). Kanno S. Gram stain. Medicina 2005;42:545–48 (in Japanese).
12.
Zurück zum Zitat Miyashita N, Shimizu H, Ouchi K, Kawasaki K, Kawai Y, Obase Y, Kobashi Y, Oka M. Assessment of the usefulness of sputum Gram stain and culture for diagnosis of community-acquired pneumonia requiring hospitalization. Med Sci Monit. 2008;14:CR171–6.PubMed Miyashita N, Shimizu H, Ouchi K, Kawasaki K, Kawai Y, Obase Y, Kobashi Y, Oka M. Assessment of the usefulness of sputum Gram stain and culture for diagnosis of community-acquired pneumonia requiring hospitalization. Med Sci Monit. 2008;14:CR171–6.PubMed
13.
Zurück zum Zitat Anevlavis S, Petroglou N, Tzavaras A, Maltezos E, Pneumatikos I, Froudarakis M, Anevlavis Bouros E. A prospective study of the diagnostic utility of sputum Gram stain in pneumonia. J Infect. 2009;59:83–9.PubMedCrossRef Anevlavis S, Petroglou N, Tzavaras A, Maltezos E, Pneumatikos I, Froudarakis M, Anevlavis Bouros E. A prospective study of the diagnostic utility of sputum Gram stain in pneumonia. J Infect. 2009;59:83–9.PubMedCrossRef
14.
Zurück zum Zitat Sato T, Aoshima M, Ohmagari N, Tada H, Chohnabayashi N. Usefulness of sputum Gram staining in community-acquired pneumonia. Nihon Kokyuki Gakkai Zasshi. 2002;40:558–63 (Abstract). Sato T, Aoshima M, Ohmagari N, Tada H, Chohnabayashi N. Usefulness of sputum Gram staining in community-acquired pneumonia. Nihon Kokyuki Gakkai Zasshi. 2002;40:558–63 (Abstract).
15.
Zurück zum Zitat Miyashita N, Matsushima T, Oka M, Japanese Respiratory Society. The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations. Intern Med. 2006;45:419–28. Miyashita N, Matsushima T, Oka M, Japanese Respiratory Society. The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations. Intern Med. 2006;45:419–28.
16.
Zurück zum Zitat Smith RP, Lipworth BJ, Cree IA, Spiers EM, Winter JH. C-reactive protein. A clinical marker in community acquired pneumonia. Chest. 1995;108:1288–91.PubMedCrossRef Smith RP, Lipworth BJ, Cree IA, Spiers EM, Winter JH. C-reactive protein. A clinical marker in community acquired pneumonia. Chest. 1995;108:1288–91.PubMedCrossRef
17.
Zurück zum Zitat Ikai H, Morimoto T, Shimbo T, Imanaka Y, Koike K. Impact of postgraduate education on physician practice for community-acquired pneumonia. J Eval Clin Pract. 2012;18:389–95.PubMedCrossRef Ikai H, Morimoto T, Shimbo T, Imanaka Y, Koike K. Impact of postgraduate education on physician practice for community-acquired pneumonia. J Eval Clin Pract. 2012;18:389–95.PubMedCrossRef
Metadaten
Titel
Usefulness of gram-stained sputum obtained just after administration of antimicrobial agents as the earliest therapeutic indicator for evaluating the effectiveness of empiric therapy in community-acquired pneumonia caused by pneumococcus or Moraxella catarrhalis
verfasst von
Ryuichi Fujisaki
Toshimori Yamaoka
Michiko Yamamura
Sayoko Kawakami
Yasuo Ono
Yukihisa Miyazawa
Tamio Teramoto
Hajime Nishiya
Publikationsdatum
01.06.2013
Verlag
Springer Japan
Erschienen in
Journal of Infection and Chemotherapy / Ausgabe 3/2013
Print ISSN: 1341-321X
Elektronische ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-012-0475-7

Weitere Artikel der Ausgabe 3/2013

Journal of Infection and Chemotherapy 3/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

SGLT2-Inhibitoren und GLP-1-Rezeptoragonisten im Schlagabtausch

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Wer hat die Nase vorn – SGLT2-Inhibitoren oder GLP-1-Rezeptoragonisten? Diese Frage diskutierten zwei Experten in einer Session auf dem diesjährigen Diabetes-Kongress.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Delir bei kritisch Kranken – Antipsychotika versus Placebo

16.05.2024 Delir nicht substanzbedingt Nachrichten

Um die Langzeitfolgen eines Delirs bei kritisch Kranken zu mildern, wird vielerorts auf eine Akuttherapie mit Antipsychotika gesetzt. Eine US-amerikanische Forschungsgruppe äußert jetzt erhebliche Vorbehalte gegen dieses Vorgehen. Denn es gibt neue Daten zum Langzeiteffekt von Haloperidol bzw. Ziprasidon versus Placebo.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.